Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2024 May 7;14:10475. doi: 10.1038/s41598-024-59899-3

Treatment of flexibility of protein backbone in simulations of protein–ligand interactions using steered molecular dynamics

Duc Toan Truong 1,2, Kiet Ho 3, Dinh Quoc Huy Pham 4, Mateusz Chwastyk 4, Thai Nguyen-Minh 5, Minh Tho Nguyen 1,2,
PMCID: PMC11076533  PMID: 38714683

Abstract

To ensure that an external force can break the interaction between a protein and a ligand, the steered molecular dynamics simulation requires a harmonic restrained potential applied to the protein backbone. A usual practice is that all or a certain number of protein’s heavy atoms or Cα atoms are fixed, being restrained by a small force. This present study reveals that while fixing both either all heavy atoms and or all Cα atoms is not a good approach, while fixing a too small number of few atoms sometimes cannot prevent the protein from rotating under the influence of the bulk water layer, and the pulled molecule may smack into the wall of the active site. We found that restraining the Cα atoms under certain conditions is more relevant. Thus, we would propose an alternative solution in which only the Cα atoms of the protein at a distance larger than 1.2 nm from the ligand are restrained. A more flexible, but not too flexible, protein will be expected to lead to a more natural release of the ligand.

Keywords: Protein–ligand complexes, Protein flexibility, Ligand affinities, Ligand release, Steered molecular dynamics simulations, Restrain modes

Subject terms: Biochemistry, Biophysics, Computational biology and bioinformatics, Chemistry

Introduction

Since its first introduction in 19861,2, the atomistic force microscopy (AFM) has provided us with a wealth of information about the mechanical properties of ligand–protein structures. Despite some fundamental limitations that have not yet been overcome3,4, the AFM technique remains a valuable tool for examining how a macromolecular target is assembled58.

In a typical AFM experiment, a spring is employed to attach a macromolecular system. In this setup, the spring is moved away from the anchored molecule at a chosen speed, generating an external force that not only affects the biological system but also allows to extract its kinetic information. Study on how proteins and ligands unbind from each other at an atomistic level is particularly interesting because these observations bring in crucial information to the field of rational drug design, including, among others, the unbinding pathways, residence time, and dissociation rate9,10.

The unbinding process of a ligand–protein complex continuously occurs over a large timescale, ranging from microseconds to several seconds11. Although current methodologies have expanded our knowledge, experimental study of this process remains a challenging task. Therefore, for a comprehensive understanding, scientific research is increasingly drawn to computational approaches that have recently played a significant role in this area thanks to rapid advances in both technical hardware and software12,13.

To replicate the principles of atomic force microscopy (AFM) experiments in silico, the steered molecular dynamics (SMD) simulation which was first developed in 19961418, has often been employed. This computational approach allows the ligand to play the role of the linker molecule, and the protein acts as the anchored one19.

A conventional SMD protocol carefully selects a pulling direction based on structural information2022. To complete a dependent trajectory the external force must successfully drive the ligand far away from the protein's active site. During this motion, both the force–time profile and displacement–time profile are recorded. Numerous SMD applications have been reported in which it cannot only be applied to generate a ligand–protein unbinding process, but also to evaluate the binding affinity following the principle that 'the larger the rupture force, the higher the binding affinity will be'21,2327. Steered molecular dynamics simulation also plays a crucial role in bioinformatics analysis and rational drug design2830.

Notably, to ensure that the ligand is pulled out of the protein interactive space, a harmonic potential needs to be applied to the protein backbone to restrain its motion. This adaptation prevents the external force from applying too much on the receptor; otherwise, the SMD performance may induce a steady drift in the water solution rather than focusing on the breaking of the ligand–protein interaction.

Grubmuller and Schuteln were known as pioneers in implementing SMD simulations14. In a study published in 1996, this group fixed all of the protein's atoms including the C, N, S and O atoms14. In two subsequent studies in 1997 and 1999, Schuteln’s research group constrained all the Ca atoms on top of the human retinoic acid receptor16 (hRAR protein) and restrained the mobility of six C atoms of the bacteriorhodopsin protein31.

Other methods used by Schuteln's group included the holding the center of mass (COM) of all the carbon atoms in the neuraminidase protein32, fixing carbon atoms of the residues 26, 31, 56, 215, 307 and 333 at the front face of the Gelsolin segment-1 protein33. Since SMD has proved to be a promising tool34 due to its fast computing, friendly implementation but with high accuracy, numerous restrained methods have been reported24,35. However, the way that previous authors restrained the protein's mobility have been found to be not consistent in going from one study to another24,3235.

In more recent studies, some authors still preferred restraining the motion of all heavy atoms, while others restrained a small group of atoms. A brief summary given in Table 1 lists a part of these inconsistencies. It is a challenging task for us to adequately summarize all related studies reported in the last three decades; it is rather the work of a comprehensive review which goes beyond the scope of the present study. According to our best summarization, when performing a SMD simulation, one of three constrained techniques has usually been employed, namely (1) fixing all heavy atoms of the protein; (2) fixing all alpha-carbon atoms of the protein, and (3) fixing some chosen Cα atoms depending on specific purposes. Moreover, in some protocols, the authors omitted to share the necessary information of their chosen method for reproduction35,36. It appears that a harmonic potential has been applied to the simulation without any rational or justification.

Table 1.

A summary of different restrain methods employed in the steered molecular dynamics simulation during the last three decades.

Nr Year Complex Fixed atoms PDB ID
1 1997 Bacteriorhodopsin and retinal (C20H28O) Six atoms, the Cα—atoms of six residues, at the ends of helices A, B, and C16 1BRD
2 1999 Human retinoic acid receptor hRAR and retinoic acid (C20H28O2) Set of atoms, all of Cα—atoms in the top part of the protein31 2LBD
3 1999 Gelsolin sesgment 1 and Adenosine-5'-triphosphate (C10H16N5O13P3) Set of atoms, all carbon atoms of residues 31, 26, 56, 215, 307, and 333 at the front face of the protein33 1EQY
4 2002 Acetylcholine receptors and huperzine A (C15H18N2O) Center of mass of AChE protein37 1VOT
5 2003 HIV-1 reverse transcriptase and (2-acetyl-5-methylanilino)(2,6-dibromophenyl)acetamide (C17H16Br2N2O2) All heavy atom38 1HNI
6 2005 Acetylcholine receptors and 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine (C24H29NO3) None report39 1EVE
7 2006 Acetylcholine receptors and acetylcholine (C7H16NO2+) One atom, a Cα of residue V-10940 1I9B
8 2010 Neuraminidase and oseltamivir carboxylate (C14H24N2O4) Center of mass of protein Cα—atoms32 2HU4, 3CL0, 3CL2
9 2015 Thrombin and C32H35BrN2O2S, neuraminidase and C11H19NO9, penicillopepsin and alpha-D-mannopyranose (C6H12O6) Set of atoms, Cα—atoms of the receptor which are 3 Å behind the last atom of the ligand41 1D3D, 1NSC, 1APT
10 2015 Bovine beta-lactoglobulin and octanoic acid (C8H16O2) Cα—atoms far from binding site are fixed42 3NQ9
11 2019 Human Adenosine A2A Receptor and C23H29N7O6, C16H15N7O2 Five atoms, Cα—atoms of five residues at the top of the transmembrane helices (residues 9, 80, 177, 256 and 270)43 4UHR, 5IU4
12 2020 Trypsin and benzamidine (C7H8N2) All Cα—atoms44 3PTB
13 2020 Human Abl kinase domain and imatinib (C29H31N7O) All backbone atoms of protein’s binding pocket45 2HYY
14 2020 RDB of Spike protein and simeprevir (C38H47N5O7S2), or lumacaftor (C24H18F2N2O5) All atoms of protein backbone46 6LZG
15 2021 Heat shock protein 90 (Hsp90) and C13H10BrN5 All Cα—atoms47 3K99
16 2022 Spike protein of SAR-2 virus and ACE2 and silodosin (C25H32F3N3O4) Cα—atoms of residues 519, 333, 360, 525, 386 and 517.48 6LZG
17 2022 Neuraminidase and capsaicin (C18H27NO3) All Cα—atoms49 2HU0

The flexibility of macromolecules has become a fundamental component that must be considered in computational modeling, especially in computational aided drug design5054. Additionally, as more crystal structures of protein–ligand complexes have been recorded, it is found that a ligand can bind to different conformations of the same receptor. These differences are induced by specific structural rearrangements of one or more amino acids located in a narrow region of the protein's active site. The flexibility of these residues predominantly affect the ligand’s behavior when that ligand is released from a crowded region5557. However, this important aspect in steered molecular dynamic simulation has not received much attention.

In a SMD study, Zhang58 changed the k-constant of the restrained harmonic potential to explore the influence of protein flexibility. This author demonstrated that a lower harmonic force applied to all C-atoms of the protein results in a larger variety of protein–ligand conformations. Except for Zhang’s study, to our best knowledge, no additional information on this aspect is available. Such an absence has indeed led to a deeper inconsistency when various restrained methods are still used in SMD simulations, as mentioned in the paragraph above (cf. Table1). Evidence from Zhang's study has clearly warned that a rigid fixing of all heavy atoms or all Cα atoms could neglect the contribution of protein motion to the unbinding process. In contrast, from the opposite viewpoint, we are concerned that a too weak restrained force or a too flexible protein is not be able to stop the drifting of the whole structure59,60. A legitimate question is what could happen when the external force focuses on stretching the protein rather than on rupturing the ligand–protein interaction.

Another issue is as to whether the entire ligand–protein complex drifts under the influence of the water bulk layer. In this context, the questions of interest that motivate the present study is how the protein motion could be restrained in SMD simulations, and what differences could be expected by these different methods.

To investigate the differences in relevant approaches, we are developing various restricted ways before applying them to the same ligand–receptor complex. To take these ways into account, we propose six parallel SMD simulation systems in which six different groups of Cα atoms of a protein are held. Unlike the previous study of Zhang58 where the author reduced the k-constant of the harmonic potential from 1000 to 5 kcal/mol.nm2, we relax in the present study the protein by narrowing the portion of the protein backbone where a restrained harmonic potential could be applied. Each of the six independent preparations is described in detail in the following section.

Under the influence of six different approaches, changes in the protein's geometric structure are expected to be observed. The ligand–protein complex chosen from the PDB Bank needs to satisfy the following conditions, namely, (a) the protein has a wide enough tunnel to prevent the ligand from collapsing the protein gorge; (b) no metallic atoms are present in the protein binding pocket6163 and (c) only one protein chain has the ability to carry out the protein’s function. During the output data collection, the intermolecular interaction between protein and ligand is calculated, including the number of contacts and the number of hydrogen bonds. The activity of every major residue located near the active site is carefully explored. The force–time dependence and the displacement–time dependence are monitored, in a similar way as in previous traditional SMD simulations. A non-equilibrium process with a smaller unbinding barrier would represent a state closer to an equilibrium process. The most sufficient way of using a restrained harmonic potential could be introduced for further investigation aiming to demonstrate the ligand–protein unbinding pathway by SMD simulation.

Materials and methods

System preparations

The PDB Bank provides atomistic structures of ligand–protein binding complexes. Ligand-contained proteins are sourced from the PDB Bank, the relevant literature, and previous reviews, etc. Six proteins including the ones noted as PDB-IDs 4JNJ, 2JFZ, 1PYE, 1TSL, 2YDV, 1EVE are selected. Before adding hydrogen atoms using the Gromacs software (version 202064), missing residues are repaired with Pymol Software65,66. The Amber ff99SB-ILDN force field is implemented. The Gaussian 1667 package is used to optimize geometry structure of the ligands and subsequently to determine the charge distribution. The ligand’s conformations are optimized and its electrostatic potential maps are calculated at the B3LYP/6–31 + G(d,p) level. Atomic net charges of the ligands are derived using the RESP68 method. The Antechamber module of AMBER Tools is applied to calculate additional parameters for the compounds using the General Amber Force Field (GAFF)69,70. Simulated cubic boxes are set to ensure a distance greater than 0.6 nm between the protein surface and boundaries. After solvating in water, Na or Cl ions are added to neutralize the system. Particle mesh Ewald (PME)71 method is used for long-range electrostatic interactions, and periodic boundary conditions are set. The SHAKE72 algorithm is applied to covalent bonds of hydrogen atoms. The non-bonded contact between two atoms is avoided when the pair distance is larger than 1.0 nm. The system preparation is similar to our previous setup.24 The tables mentioned above, (Table 2 and Tables S1 and S2 in the Supplementary Information file (SI)) list the PDB-IDs of the complexes utilized. Pulling directions are identified based on the support of the Carver web server version 1.0 and aligned to the Z—axis of coordinate systems73.

Table 2.

General information of simulation.

PDB-ID 4JNJ 2JFZ 1PYE 1TSL 2YDV 1EVE
Name Streptavidin monomer Glutamate racemase Cyclin dependent kinase Bacterial thymidylate synthase Adenosine A2 receptors Acetylcholinesterase AChE
(a) General information of protein—ligand system
 Protein's number residues 115 255 298 316 325 534
 System's number atoms 26.860 37.453 43.552 52.649 64.288 89.132
(b) Number of Carbon alpha atoms be fixed in a restrained method
 PDB-ID 4JNJ 2JFZ 1PYE 1TSL 2YDV 1EVE
 Mode 1 774 1758 1885 2278 1923 3730
 Mode 2 115 255 298 316 325 534
 Mode 3 49 173 134 201 120 304
 Mode 4 44 161 85 183 119 234
 Mode 5 21 58 22 68 44 69
 Mode 6 5 27 3 41 22 44

Restraining method

The present study aims to determine the influence of different restrained methods on the results obtained by conventional steered molecular dynamic simulations. Six ways of fixing protein backbone are prepared: (1) fixing all heavy atoms of protein (C, N, S, O); (2) fixing all Cα atoms of protein; (3) fixing all Cα atoms with a distance to ligand greater than 1.2 nm; (4) fixing all Cα atoms with the perpendicular distance in the pulling direction to ligand greater than 1.2 nm; (5) fixing all Cα atoms with the perpendicular distance in the pulling direction to ligand greater than 1.2 nm and all Cα atoms with the perpendicular distance in the x–y direction to ligand smaller than 1.2 nm, and (6) fixing all Cα atoms with the perpendicular distance in the pulling direction to ligand greater than 1.8 nm and all Cα atoms with the perpendicular distance in the x–y direction to ligand smaller than 1.2 nm. Six groups of protein atoms are presented in Fig. 1. In the discussion hereafter, each way of fixing is named as mode, from mode 1 to mode 6 corresponding to the six fixing conditions defined above.

Figure 1.

Figure 1

Cartoon mapping of five restrained modes from 2 to 6. Representative group of atoms of CDK-2 protein, PDB-ID 1PYE (lower). Y–Z directions are shown in (2) (restraining all heavy atoms not shown). Small images are arranged from 2 to 6, respectively, with increasing protein flexibility.

Steered molecular dynamics simulations

Some of the complexes selected here have already been examined in previous studies39,74. However, creating uniformity within existing results is not possible due to large variations in parameters including force field, pulling velocity, and the pulling direction-defined method… implemented in those protocols. Therefore, simulations with a consistent set of parameters are carried out. In our protocol, a hundred independent trajectories will be performed in each mode of the restrained method. A constant pulling velocity (v = 1.0 nm/ns) and a spring constant (k = 600 kJ/mol/nm2) are chosen. Snapshots are saved every 5000 steps (2 fs for each step). The duration time of pulling is set to 3 ns to ensure that all ligands are pulled far away from the protein. In each trajectory, the time-dependent force/displacement is recorded every 10 fs. External pulling work and unbinding barrier free energy are computed using the protocol defined in our previous studies24.

Hydrogen bond and contact

When a protein's heavy atom has the smallest distance to one atom of the ligand, being less than 0.6 nm, an intermolecular contact is formed. If the acceptor–donor distance is less than 0.35 nm and the acceptor-hydrogen-donor angle is greater than 1350, a hydrogen bond is considered available. Tasks are performed using the Gromacs packages including gmx hbond and gmx mindist. All hydrogen bonds created between inhibitors and the receptors are taken into account. In each snapshot of an independent SMD trajectory, the number of hydrogen bonds and the ligand's center of mass (COM) are analyzed. Following this way, we can average the number of hydrogen bonds depending on the position of the COM.

Protein root mean square deviation

The root mean square deviation (RMSD) of the protein is calculated as the dissimilarity of all atom coordinates to its initial structure in three dimensions. These analytical procedures are carried out using the gmx_rms tool supported in the Gromacs package, and the appropriate formula is as follows:

RMSD(x,xref)=1Ni=1N(xi-xiref2

where N is the number of atoms of the protein, and x represents the three-dimensional coordinate.

Results and discussion

Convergence of numerical data and distorted Gaussian-type distribution of values

Every physical quantity considered in this study is derived from a non-equilibrium process. Due to our limited computing power, we could only apply a fast growth evolution when the pulling velocity is chosen at 1 nm/ns. In replicating the results of the AFM experiment and analyzing the SMD data, we monitor the time-dependent force and record the maximum value, known as Fmax, right after a rupture event occurred. To achieve the outcome convergence, previous studies have indicated that steered molecular dynamics (SMD) simulations require a suitable number of independent trajectories, neither too large nor too small. In the context of using a relatively small velocity (v = 1 m/s), although there are minor differences in the number of trajectories each system required to reach result convergence, we recognize that about 100 orbits are sufficiently large for all of them. Figure 2 serves as an example, including the rupture force and external work in dependence on the number of pulling trajectories. Accordingly (Fig. 2), data convergence is found in every restraint mode, from mode 1 to mode 6, and in every ligand–protein complex (data not shown).

Figure 2.

Figure 2

Figure 2

The mean value of rupture force (left) and external work (right) dependent on the number of pulling trajectories. Data are obtained from six restrained modes of the 4JNJ system, with 100 independent pulling trajectories in each mode: mode 1 (in magenta), mode 2 (in orange), mode 3 (in blue), mode 4 (in green), mode 5 (in red), and mode 6 (in black). The distribution of rupture force (middle—right) and the distribution of pulling work (right) show a distorted Gaussian curve (black line).

Force–time and work-time profile obtained from different restrained modes of the ligand release

All values of Fmax and Wpull are listed in Table 3. Overall, mode 1 and mode 2 of every system are consistently held the first and second positions, significantly larger than the others. The mean values of rupture force and pulling work from 100 trajectories of each pulling mode are taken into account, as shown in Table 3. Restraining all heavy atoms revealed values of 983 pN, 1440 pN, 1594 pN, 2010 pN, 1147 pN, 917 pN for Fmax and 90.5, 160.1, 210.2, 301.0, 140.9 and 87.4 kcal/mol for Wpull, in the cases of 1EVE, 2JFZ, 2YDV, 4JNJ, 1PYE and 1TSL systems, respectively. In the case of restraining all carbon atoms, Fmax is decreased to values of 694 pN, 688 pN, 833.7 pN, 1590 pN, 721 pN, 523 pN, and Wpull lowered to 58.1, 47.2, 96.2, 193, 63.1, and 38.2 kcal/mol, respectively. In summary, based on the analysis of Fmax and Wpull, we recognize that our six fixing methods may be classified into two main classes: (A) rigidly fixing including mode 1, mode 2 and B) flexibly fixing including mode 3 to mode 6. When compared to the corresponding quantities in four flexible modes, the mean values of rupture forces and pulling works in two rigidly fixing methods of class A are outstandingly higher.

Table 3.

The averaged value of rupture force (a), pulling work (b), unbinding barrier (c) and root-mean-square deviation (d) obtained from 100 independent trajectories.

PDB-ID 4JNJ 2JFZ 1PYE 1TSL 2YDV 1EVE
(a) Rupture force (pN)
 Mode 1 2010 ± 12 1440 ± 5 1147 ± 24 917 ± 6 1594.8 ± 8.7 983 ± 4
 Mode 2 1590 ± 14 688 ± 8 721 ± 13 523 ± 7 833.7 ± 8.6 694 ± 8
 Mode 3 1214 ± 14 473 ± 7 537 ± 11 377 ± 6 539.7 ± 11.3 629 ± 7
 Mode 4 1192 ± 15 453 ± 8 499 ± 9 344 ± 7 530.7 ± 10 608 ± 7
 Mode 5 1200 ± 14 422 ± 7 447 ± 11 344 ± 6 537.6 ± 7.7 597 ± 7
 Mode 6 874 ± 11 398 ± 8 411 ± 10 337 ± 6 523.1 ± 9 605 ± 7
(b) Pulling work (kcal/mol)
 Mode 1 301 ± 3 160.1 ± 1.1 140.9 ± 3.3 87.4 ± 0.9 210.3 ± 1.8 90.5 ± 0.6
 Mode 2 193 ± 3 47.2 ± 0.7 63.1 ± 1.4 38.2 ± 0.8 96.2 ± 1.4 58.1 ± 0.8
 Mode 3 122 ± 2 30.4 ± 0.6 48.7 ± 1.6 25.2 ± 0.8 53.5 ± 1.3 52.8 ± 0.8
 Mode 4 115 ± 2 27.8 ± 0.6 44.1 ± 1.5 18.5 ± 0.9 52.6 ± 1.3 51.2 ± 0.8
 Mode 5 116 ± 2 26.7 ± 0.6 32.3 ± 1.5 21.2 ± 0.9 55.2 ± 1.1 51.9 ± 0.9
 Mode 6 124 ± 2 25 ± 0.7 30 ± 1.5 21.6 ± 0.9 54.6 ± 1.4 54.8 ± 0.9
(c) Unbinding barrier (kcal/mol)
 Mode 1 290.3 ± 3.5 147.2 ± 1.1 99.3 ± 4.2 45.4 ± 0.7 168.1 ± 1.9 60.2 ± 0.6
 Mode 2 179.6 ± 3.1 35.4 ± 0.8 37.2 ± 1.5 15.7 ± 0.5 49.8 ± 1.1 27.3 ± 0.7
 Mode 3 106.7 ± 2.4 16.6 ± 0.5 19.4 ± 0.8 10.3 ± 0.4 21.5 ± 1.2 21.8 ± 0.6
 Mode 4 101.9 ± 2.6 15.9 ± 0.6 17.1 ± 0.8 9.2 ± 0.4 20.7 ± 0.9 21.7 ± 0.6
 Mode 5 102.7 ± 2.3 13.8 ± 0.5 15.0 ± 0.7 8.4 ± 0.3 20.5 ± 0.7 18.9 ± 0.7
 Mode 6 24.6 ± 0.6 12.5 ± 0.5 12.1 ± 0.5 8.2 ± 0.3 19.5 ± 0.7 18.1 ± 0.6
(d) Averaging RMSD value (A0) of protein backbone at final SMD step
 Mode 1 0.247 ± 0.001 0.231 ± 0.001 0.211 ± 0.001 0.226 ± 0.001 0.229 ± 0.001 0.226 ± 0.001
 Mode 2 0.405 ± 0.003 0.407 ± 0.002 0.428 ± 0.002 0.411 ± 0.002 0.422 ± 0.002 0.396 ± 0.001
 Mode 3 0.84 ± 0.02 0.73 ± 0.01 0.89 ± 0.02 0.92 ± 0.023 1.22 ± 0.02 0.663 ± 0.006
 Mode 4 0.99 ± 0.02 0.83 ± 0.01 0.975 ± 0.026 1.68 ± 0.04 1.22 ± 0.02 1.01 ± 0.01
 Mode 5 1.0 ± 0.02 1.15 ± 0.02 1.17 ± 0.03 2.04 ± 0.06 1.64 ± 0.02 1.19 ± 0.01
 Mode 6 1.85 ± 0.07 1.32 ± 0.02 1.51 ± 0.03 1.91 ± 0.06 1.76 ± 0.03 1.22 ± 0.01

Over the past two decades, there has been much discussion about how a pulling rate14,75,76 influences the rupture force and external work of a non-equilibrium process. There is a consensus that a decrease of the pulling rate does not only decrease the rupture force and the external work but also push the non-equilibrium process to evolve into an equilibrium one. In other words, the smaller the value we obtain, the faster the system reaches an equilibrium. According to this knowledge, neither mode 1 nor mode 2 is expected to attain a sufficient way to generate a natural process of ligand–protein dissociation. This information could normally be predicted, but our evidence serves as a useful warning for an eventual selection of mode 1 or mode 2 in a SMD simulation. Figure 3 shows the time-dependent pulling force, displacement, RMSD, and external work in a representative trajectory from pulling the 4JNJ system. The averaged lines from 100 trajectories are shown in Figs. S1S6 of the SI file.

Figure 3.

Figure 3

Time-dependent force (upper-left) and time-dependent ligand's displacement (upper-right), time-dependent work (lower-left), and time-dependent RMSD (root mean square deviation) (lower-right). Results are randomly plotted from six representative trajectories under six different restrained methods of the 4JNJ system. Averaged values of rupture force and pulling work, obtained over 100 trajectories in six systems, are shown in the SI file.

In the paragraph above, we mention that the modes in class A have stronger rupture forces and larger pulling works, that are outstanding as compared to the outcomes attained by the approaches in class B. Here we are going into more detail about the results of simulations generated using lighter restraining approaches, from mode 3 to mode 6. Collected data in almost all cases, listed in Table 3, seem to interpret two common understandings, namely, i) the more flexible the protein is, the smaller the rupture force will be, and ii) the more flexible the protein is, the lower the pulling work the external force will perform.

When examining the 1EVE system, the mean rupture forces in modes 4, 5 and 6 are measured at values: 608 ± 7 pN, 597 ± 7 pN, 605 ± 7 pN. Similarities are also detected in the 2YDV system and 4JNJ system, modes 3, 4 and 5; in 1TSL system, modes 4, 5and 6. A question of concern is as to whether there is any misinformation. It is reasonable to see that these equivalent values of Fmax are caused due to the geometric feature of protein structure where some distinct modes have restrained some quite similar groups of Cα atoms. Protein 1EVE and 1TSL are formed from globulin structures while 2YDV and 4JNJ are formed via beta-barrel structures. Data collected from our simulations truly confirm the first statements given above. To prove the second statement, we now calculate the pulling work.

Looking now at mode 6 in all systems considered, although six systems create the smallest value of averaging rupture forces Fmax, the mean value of pulling work Wpull is not always the lowest one. There are 4/6 protein–ligand complexes like that. The systems 1EVE and 4JNJ, under mode 6 conditions, have received the mean values Wpull of 54.8 kcal/mol and 124 kcal/mol, respectively. These results are higher than the mean value of pulling work in mode 5, which are 51.9 kcal/mol and 116 kcal/mol.

To investigate these issues, we plot in Fig. 3 four curves including the time-dependent force, the time-dependent displacement, the time-dependent work, and the time-dependent root-mean-square deviation (RMSD) from one representative trajectory in the 4JNJ system. According to the RMSD black line (in Fig. 3), it is rather easy to recognize that the ligand leaves its initial position immediately when the external force starts increasing. The averaged value of RMSD of the protein backbone is collected in Table 3. Since mode 5 and mode 6 usually own a higher amount of averaged RMSD, this raises a suspect: instead of breaking the protein–ligand dissociation, the external force aims to stretch the protein and induce an unnecessary value of pulling work. More seriously, we also find in some cases of mode 6: the bulk water layer induces the protein to spin perpendicularly to the pulling direction. The ligand thereby collapses to the protein wall as captured in Fig. S25 (SI file). Although waste trajectories are not appeared frequently and are manually ejected in this examination, this leads to more concerns when using mode 6 or even mode 5 in the steered molecular dynamic simulations.

Flexibly restraining mode lowers the unbinding barrier for ligand crossing

In the biophysical literature, an unbinding process is usually conceptualized as a barrier crossing in which the system is transformed from a higher free energy conformation to a lower. Thus, we now construct the free energy profile of a relevant non-equilibrium kinetic process22. The unbinding free energy barriers of six 4JNJ representative trajectories are plotted in Fig. 4. Collected results show that if all heavy atoms of the protein are constrained, ligands must overcome the highest energy barrier to successfully escape far away from the protein.

Figure 4.

Figure 4

Free energy profile of six representative trajectories when a ligand was pulled out of the streptavidin protein, PDB ID 4JNJ. Results are obtained under six restrained methods.

Every complex clearly displays the remarkable values of mode 1 and mode 2 unbinding barriers which are listed in part (c) of Table 3. In the case of 1EVE, a globulin protein complex, two highly fixing strategies, all heavy atoms mode 1 and all Cα atoms mode 2, give the mean values of 60.2 kcal/mol and 27.3 kcal/mol, respectively, whereas the mode 6 restrained method only produces an unbinding barrier of 18.1 kcal/mol. All other protein–ligand complexes likewise exhibit a notable variation between the unbinding barrier's lowest value and its two greatest values. The ligand in the case of the least tightly fixing approach needs to cross small barriers of 12.1 kcal/mol for 1PYE, 12.5 kcal/mol for 2JFZ, 19.5 kcal/mol for 2YDV, 24.6 kcal/mol for 4JNJ and 8.2 kcal/mol for 1TSL. In contrast, all remarkable values of mode 1 and mode 2 are recorded at 99.3 and 37.2 kcal/mol for 1PYE, 147.2 and 35.4 kcal/mol for 2JFZ, 168.1 and 49.8 kcal/mol for 2YDV, 290.3 and 179.6 kcal/mol for 4JNJ, 45.4 and 15.7 kcal/mol for 1TSL. The mean curves of unbinding free energy from six systems are shown in Figs. S13S18 of the SI file. When all free energy profiles are established it is easy to find that the unbinding barrier tends to decrease in the context of relaxing the protein.

Flexibly restraining mode allows more residues to form contact with ligand

In order to better comprehend about how changes in protein structure could affect the ligand escape, we explore in this paragraph the interactions between proteins and ligands. Looking over 100 trajectories of a mode and 300 frames in each trajectory, a few steps are carried out: (1) we count the number of residues that make at least one contact with the ligand; full data are collected in Table S2(SI file), (2) we figure out the averaging number of hydrogen bonds in dependence on displacement, and (3) we plot the curve of the displacement-dependent interaction energy (IE).

Interestingly, the flexibility of the protein is found to be diversified with respect to the protein–ligand interactive picture, because more residues are found to be coming into contact with the ligand during the dissociation process. Table S2 (SI file) shows the number of residues that have a time being in contact with the ligand. With 1EVE system, mode 1 results in only 55 residues that form contact with the ligand during the ligand exit. For mode 2 through mode 6, this quantity rises from 59, 66, 69, 70 to 72 residues. The proportional increase of this quantity of 1TSL and 2YDV systems is illustrated in Fig. 5.

Figure 5.

Figure 5

Number of residues that are formed at least with one contact with the ligand during its escape. Data are obtained over 100 independent trajectories. Data of mode 1 are not shown for the sake of clarity.

In all complexes considered, numerical data indicates that the use of mode 1 and mode 2 tends to prevent the ability of the protein and narrow the space of configuration sampling. Notably, our displacement-dependent number of hydrogen bond in Fig. 6 and Figs. S20S24 (SI file) demonstrates that this increase is mostly derived in the period of time after the rupture event occurs. That leads to a conclusion that when the protein is relaxed, it increases the fluctuation of residues in the nearby region. A simple fixing of the atoms allows as much as possible the residues to participate in the interaction with ligand. From the point of view of a natural event, a participation of more residues seems to encourage the ligand escaping. This observation needs to be explored with more evidence in the subsequent investigations.

Figure 6.

Figure 6

Averaging the interaction energy (left) and number of hydrogen bonds per frame (right) in the dependence of displacement obtained from the 4JNJ system under six restrained modes: mode 1 (in magenta), mode 2 (in orange), mode 3 (in blue), mode 4 (in green), mode 5 (in red), and mode 6 (in black).

Flexibly restraining mode lengthens the ligand–protein harmonic potential

For a deeper analysis of the SMD simulations, we compute the interaction energy (IE) between both inhibitors and receptor, as a summation of polar (Coulomb) and non-polar (Van der Waals) interaction:

IE=VL-PVdW+VL-PCou.

Each snapshot of saving data is submitted into one MD-step run for computing the ligand–protein interaction. Then the profile of non-bound interaction energy plotted within the dependence on ligand’s displacement is shown in Fig. 6. The full image of the interaction energies, the Coulomb potentials, and the Van der Waals potentials is shown in the SI file, from Figs. S7S12. In particular, the length (L0) of the ligand–protein interaction potential is found to be changed as a result of the protein flexibility, which has ever been assumed to be constant in a previous theoretical study60. Notably, the interaction energy between the protein and ligand in the 4JNJ system is decreased into zero at the displacement of 0.5 nm (mode 2) and 2.0 nm (mode 6). This illustrates a significant difference from the smallest value of a narrower potential to the largest one of a wider potential. Since the length (L0) is an important parameter to construct the analytical expression of the protein–ligand harmonic potential, our collected data will make a reference to the building of the dependence of work on the pulling velocity in SMD study76.

Concluding remarks

In summary, we have presented in the theoretical study six approaches for restraining the protein movement during a steered molecular dynamics simulation. Some mean values of rupture force and pulling work from neighboring modes, with the standard error added, are indistinguishable from each other. This is caused by the geometric features of the protein structure, where two neighboring modes are found to restrain quite similarly the groups of Cα atoms. The most important fact recognized in this scheme is that the 1st and 2nd standing positions, according to the largest values of Fmax and Wpull obtained from modes 1 and 2, are clear-cut and invariant. This observation confirms that restrain of all heavy atoms or all Cα atoms cannot be considered as a good choice in applying steered molecular dynamics simulations.

Because significantly larger values have been generated in modes 1 and 2, it will create more difficulty when trying to come closer to an equilibrium dissociation. In contrast, if the protein is too flexible, the force will occasionally be applied primarily to stretching the protein structure rather than breaking the bonds between the ligand and amino acids. Unnecessary work could be additionally created. This leads to incorrect information and much challenge for the use of the pulling work method to determine the binding affinities between small molecules and macro proteins. More seriously, bulk water layer may push the protein rotating. Although it is rather hard to give a quantitative suggestion for every kind of protein, we would recommend a sufficiently suitable approach for applying in SMD simulations, that is fixing all Cα atoms at a distance larger than 1.2 nm from the ligand, as we have applied in mode 3 and mode 4.

Determination of a physical pathway for ligand release or entering is always a principle in molecular dynamic simulations. The evidence obtained in this study has raised a common status, that is, let protein move flexibly in such a way that the ligand can move out of the protein binding pocket. Lower unbinding energy barriers, lower pulling work, lower rupture force constitute a strong set of foundation for an easier escape of the ligand. In addition, a certain suspicion emerges, as to whether a protein, in the natural process when external force is absent, intentionally transform to release the ligand. We have reason to believe in the entrance or release process of the ligand, many intermediate structures of the protein impact more importantly than a functional conformation when protein has successfully folded. This issue is still not clear because of the limitation of protein-mediated conformations. Relatively little is actually known on the observed effect to reveal the role of mediated conformations.

Supplementary Information

Acknowledgements

DTT and MTN are grateful to Van Lang University for support. MCh received support from the National Science Centre (NCN), Poland, under grant No. 2018/31/B/NZ1/00047. The computer resources were supported by the PL-GRID infrastructure.

Author contributions

TDT: Conception, data acquisition and interpretation of the results, manuscript preparation. KH: Calculations and analysis of the results. DQHP: Calculations and analysis of the results. MCh: analysis of the results and manuscript preparation. TNM: Analysis of the results. MTN: conception, project supervision, manuscript editing. All authors reviewed the manuscript.

Data availability

Data including calculated results of SMD simulations are available in a pdf file while the input files are given in a zip file of the Electronic Supplementary Information (ESI).

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-59899-3.

References

  • 1.Robinson AL. Electron Microscope Inventors Share Nobel Physics Prize: Ernst Ruska built the first electron microscope in 1931; Gerd Binnig and Heinrich Rohrer developed the scanning tunneling microscope 50 years later. Science. 1986;234:821–822. doi: 10.1126/science.234.4778.821. [DOI] [PubMed] [Google Scholar]
  • 2.Rugar D, Hansma P. Atomic force microscopy. Phys. Today. 1990;43:23–30. doi: 10.1063/1.881238. [DOI] [Google Scholar]
  • 3.Lo Giudice C, Dumitru AC, Alsteens D. Probing ligand-receptor bonds in physiologically relevant conditions using AFM. Anal. Bioanal. Chem. 2019;411:6549–6559. doi: 10.1007/s00216-019-02077-6. [DOI] [PubMed] [Google Scholar]
  • 4.Koehler M, et al. Control of ligand-binding specificity using photocleavable linkers in AFM force spectroscopy. Nano Lett. 2020;20:4038–4042. doi: 10.1021/acs.nanolett.0c01426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fritz J, Katopodis AG, Kolbinger F, Anselmetti D. Force-mediated kinetics of single P-selectin/ligand complexes observed by atomic force microscopy. Proc. Natl. Acad. Sci. U. S. A. 1998;95:12283–12288. doi: 10.1073/pnas.95.21.12283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lemoine P, Dooley C, Morelli A, Harrison E, Dixon D. AFM study of organic ligand packing on gold for nanoparticle drug delivery applications. Appl. Surf. Sci. 2022;574:151386. doi: 10.1016/j.apsusc.2021.151386. [DOI] [Google Scholar]
  • 7.Chowdhury N, Bagchi A. A drug repurposing endeavor to discover a multi-targeting ligand against RhlR and LasR proteins from opportunistic human pathogen Pseudomonas aeruginosa. J. Mol. Model. 2022;28:295. doi: 10.1007/s00894-022-05301-w. [DOI] [PubMed] [Google Scholar]
  • 8.Legittimo F, Marini M, Stassi S, Di Fabrizio E, Ricciardi C. Real-time monitoring of temperature-dependent structural transitions in DNA nanomechanical resonators: Unveiling the DNA–ligand interactions for biomedical applications. ACS Appl. Nano Mater. 2023;6:2249–2257. doi: 10.1021/acsanm.2c05601. [DOI] [Google Scholar]
  • 9.Copeland RA, Pompliano DL, Meek TD. Drug-target residence time and its implications for lead optimization. Nat. Rev. Drug Discov. 2006;5:730–739. doi: 10.1038/nrd2082. [DOI] [PubMed] [Google Scholar]
  • 10.Nunez S, Venhorst J, Kruse CG. Target-drug interactions: First principles and their application to drug discovery. Drug Discov. Today. 2012;17:10–22. doi: 10.1016/j.drudis.2011.06.013. [DOI] [PubMed] [Google Scholar]
  • 11.Shamir M, Bar-On Y, Phillips R, Milo R. SnapShot: Timescales in cell biology. Cell. 2016;164:1302–1302 e1301. doi: 10.1016/j.cell.2016.02.058. [DOI] [PubMed] [Google Scholar]
  • 12.Bryant, R., Katz, R. H. & Lazowska, E. D. (December, 2008).
  • 13.Klco N, Roggero A, Savage MJ. Standard model physics and the digital quantum revolution: Thoughts about the interface. Rep. Prog. Phys. 2022;85:064301. doi: 10.1088/1361-6633/ac58a4. [DOI] [PubMed] [Google Scholar]
  • 14.Grubmuller H, Heymann B, Tavan P. Ligand binding: Molecular mechanics calculation of the streptavidin-biotin rupture force. Science. 1996;271:997–999. doi: 10.1126/science.271.5251.997. [DOI] [PubMed] [Google Scholar]
  • 15.Evans E, Ritchie K. Dynamic strength of molecular adhesion bonds. Biophys. J. 1997;72:1541–1555. doi: 10.1016/S0006-3495(97)78802-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Isralewitz B, Izrailev S, Schulten K. Binding pathway of retinal to bacterio-opsin: A prediction by molecular dynamics simulations. Biophys. J. 1997;73:2972–2979. doi: 10.1016/S0006-3495(97)78326-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Izrailev S, Stepaniants S, Balsera M, Oono Y, Schulten K. Molecular dynamics study of unbinding of the avidin-biotin complex. Biophys. J. 1997;72:1568–1581. doi: 10.1016/S0006-3495(97)78804-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rief M, Gautel M, Oesterhelt F, Fernandez JM, Gaub HE. Reversible unfolding of individual titin immunoglobulin domains by AFM. Science. 1997;276:1109–1112. doi: 10.1126/science.276.5315.1109. [DOI] [PubMed] [Google Scholar]
  • 19.Heymann B, Grubmüller H. AN02/DNP-hapten unbinding forces studied by molecular dynamics atomic force microscopy simulations. Chem. Phys. Lett. 1999;303:1–9. doi: 10.1016/s0009-2614(99)00183-9. [DOI] [Google Scholar]
  • 20.Chovancova E, et al. CAVER 3.0: A tool for the analysis of transport pathways in dynamic protein structures. PLoS Comput. Biol. 2012;8:e1002708. doi: 10.1371/journal.pcbi.1002708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chwastyk M, et al. Theoretical tests of the mechanical protection strategy in protein nanomechanics. Proteins. 2014;82:717–726. doi: 10.1002/prot.24436. [DOI] [PubMed] [Google Scholar]
  • 22.Zhao Y, Chwastyk M, Cieplak M. Structural entanglements in protein complexes. J. Chem. Phys. 2017;146:225102. doi: 10.1063/1.4985221. [DOI] [PubMed] [Google Scholar]
  • 23.Nguyen HL, Thai NQ, Truong DT, Li MS. Remdesivir strongly binds to both RNA-dependent RNA polymerase and main protease of SARS-CoV-2: Evidence from molecular simulations. J. Phys. Chem. B. 2020;124:11337–11348. doi: 10.1021/acs.jpcb.0c07312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Truong DT, Li MS. Probing the binding affinity by Jarzynski's nonequilibrium binding free energy and rupture time. J. Phys. Chem. B. 2018;122:4693–4699. doi: 10.1021/acs.jpcb.8b02137. [DOI] [PubMed] [Google Scholar]
  • 25.Gunnoo M, et al. Steered molecular dynamics simulations reveal the role of Ca(2+) in regulating mechanostability of cellulose-binding proteins. Phys. Chem. Chem. Phys. 2018;20:22674–22680. doi: 10.1039/c8cp00925b. [DOI] [PubMed] [Google Scholar]
  • 26.Chwastyk M, Bernaola AP, Cieplak M. Statistical radii associated with amino acids to determine the contact map: fixing the structure of a type I cohesin domain in the Clostridium thermocellum cellulosome. Phys. Biol. 2015;12:046002. doi: 10.1088/1478-3975/12/4/046002. [DOI] [PubMed] [Google Scholar]
  • 27.Zhao Y, Chwastyk M, Cieplak M. Topological transformations in proteins: Effects of heating and proximity of an interface. Sci. Rep. 2017;7:39851. doi: 10.1038/srep39851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Li MS. Ligand migration and steered molecular dynamics in drug discovery: Comment on "Ligand diffusion in proteins via enhanced sampling in molecular dynamics" by Jakub Rydzewski and Wieslaw Nowak. Phys. Life Rev. 2017;22–23:79–81. doi: 10.1016/j.plrev.2017.08.006. [DOI] [PubMed] [Google Scholar]
  • 29.Iida S, Tomoshi K. Free energy and kinetic rate calculation via non-equilibrium molecular simulation: Application to biomolecules. Biophys. Rev. 2022;14:1303–1314. doi: 10.1007/s12551-022-01036-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Do PC, Lee EH, Le L. Steered molecular dynamics simulation in rational drug design. J. Chem. Inf. Model. 2018;58:1473–1482. doi: 10.1021/acs.jcim.8b00261. [DOI] [PubMed] [Google Scholar]
  • 31.Kosztin D, Izrailev S, Schulten K. Unbinding of retinoic acid from its receptor studied by steered molecular dynamics. Biophys. J. 1999;76:188–197. doi: 10.1016/S0006-3495(99)77188-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Le L, Lee EH, Hardy DJ, Truong TN, Schulten K. Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases. PLoS Comput. Biol. 2010;6:e1000939. doi: 10.1371/journal.pcbi.1000939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wriggers W, Schulten K. Investigating a back door mechanism of actin phosphate release by steered molecular dynamics. Proteins. 1999;35:262–273. doi: 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  • 34.Suan Li M, Khanh Mai B. Steered molecular dynamics-a promising tool for drug design. Curr. Bioinform. 2012;7:342–351. doi: 10.2174/157489312803901009. [DOI] [Google Scholar]
  • 35.Mai BK, Li MS. Neuraminidase inhibitor R-125489–a promising drug for treating influenza virus: Steered molecular dynamics approach. Biochem. Biophys. Res. Commun. 2011;410:688–691. doi: 10.1016/j.bbrc.2011.06.057. [DOI] [PubMed] [Google Scholar]
  • 36.Nicolini P, Frezzato D, Gellini C, Bizzarri M, Chelli R. Toward quantitative estimates of binding affinities for protein-ligand systems involving large inhibitor compounds: A steered molecular dynamics simulation route. J. Comput. Chem. 2013;34:1561–1576. doi: 10.1002/jcc.23286. [DOI] [PubMed] [Google Scholar]
  • 37.Xu Y, et al. How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations. J. Am. Chem. Soc. 2003;125:11340–11349. doi: 10.1021/ja029775t. [DOI] [PubMed] [Google Scholar]
  • 38.Shen L, et al. Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT. Biophys. J. 2003;84:3547–3563. doi: 10.1016/S0006-3495(03)75088-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Niu C, et al. Dynamic mechanism of E2020 binding to acetylcholinesterase: A steered molecular dynamics simulation. J. Phys. Chem. B. 2005;109:23730–23738. doi: 10.1021/jp0552877. [DOI] [PubMed] [Google Scholar]
  • 40.Zhang D, Gullingsrud J, McCammon JA. Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain. J. Am. Chem. Soc. 2006;128:3019–3026. doi: 10.1021/ja057292u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Vuong QV, Nguyen TT, Li MS. A new method for navigating optimal direction for pulling ligand from binding pocket: Application to ranking binding affinity by steered molecular dynamics. J. Chem. Inf. Model. 2015;55:2731–2738. doi: 10.1021/acs.jcim.5b00386. [DOI] [PubMed] [Google Scholar]
  • 42.Chen LY. Hybrid steered molecular dynamics approach to computing absolute binding free energy of ligand-protein complexes: A brute force approach that is fast and accurate. J. Chem. Theory Comput. 2015;11:1928–1938. doi: 10.1021/ct501162f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Potterton A, et al. Ensemble-based steered molecular dynamics predicts relative residence time of A(2A) receptor binders. J. Chem. Theory Comput. 2019;15:3316–3330. doi: 10.1021/acs.jctc.8b01270. [DOI] [PubMed] [Google Scholar]
  • 44.Wolf S, Lickert B, Bray S, Stock G. Multisecond ligand dissociation dynamics from atomistic simulations. Nat. Commun. 2020;11:2918. doi: 10.1038/s41467-020-16655-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Paul F, Thomas T, Roux B. Diversity of long-lived intermediates along the binding pathway of imatinib to abl kinase revealed by MD simulations. J. Chem. Theory Comput. 2020;16:7852–7865. doi: 10.1021/acs.jctc.0c00739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Trezza A, Iovinelli D, Santucci A, Prischi F, Spiga O. An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors. Sci. Rep. 2020;10:13866. doi: 10.1038/s41598-020-70863-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Cao DT, et al. Molecular design of anticancer drugs from marine fungi derivatives. RSC Adv. 2021;11:20173–20179. doi: 10.1039/d1ra01855h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Awad IE, Abu-Saleh AAA, Sharma S, Yadav A, Poirier RA. High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein. J. Biomol. Struct. Dyn. 2022;40:2099–2112. doi: 10.1080/07391102.2020.1835721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sedighpour D, Taghizadeh H. The effects of mutation on the drug binding affinity of Neuraminidase: Case study of Capsaicin using steered molecular dynamics simulation. J. Mol. Model. 2022;28:36. doi: 10.1007/s00894-021-05005-7. [DOI] [PubMed] [Google Scholar]
  • 50.Davis AM, Teague SJ. Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis. Angew Chem. Int. Ed. Engl. 1999;38:736–749. doi: 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  • 51.Carlson HA. Protein flexibility is an important component of structure-based drug discovery. Curr. Pharm. Des. 2002;8:1571–1578. doi: 10.2174/1381612023394232. [DOI] [PubMed] [Google Scholar]
  • 52.Adcock SA, McCammon JA. Molecular dynamics: Survey of methods for simulating the activity of proteins. Chem. Rev. 2006;106:1589–1615. doi: 10.1021/cr040426m. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Teague SJ. Implications of protein flexibility for drug discovery. Nat. Rev. Drug Discov. 2003;2:527–541. doi: 10.1038/nrd1129. [DOI] [PubMed] [Google Scholar]
  • 54.Amaral M, et al. Protein conformational flexibility modulates kinetics and thermodynamics of drug binding. Nat. Commun. 2017;8:2276. doi: 10.1038/s41467-017-02258-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Stank A, Kokh DB, Fuller JC, Wade RC. Protein binding pocket dynamics. Acc Chem. Res. 2016;49:809–815. doi: 10.1021/acs.accounts.5b00516. [DOI] [PubMed] [Google Scholar]
  • 56.Fang Y, et al. Catalytic reactions within the cavity of coordination cages. Chem. Soc. Rev. 2019;48:4707–4730. doi: 10.1039/c9cs00091g. [DOI] [PubMed] [Google Scholar]
  • 57.Kokkonen P, Bednar D, Pinto G, Prokop Z, Damborsky J. Engineering enzyme access tunnels. Biotechnol. Adv. 2019;37:107386. doi: 10.1016/j.biotechadv.2019.04.008. [DOI] [PubMed] [Google Scholar]
  • 58.Zhang Z, et al. Steered molecular dynamics study of inhibitor binding in the internal binding site in dehaloperoxidase-hemoglobin. Biophys. Chem. 2016;211:28–38. doi: 10.1016/j.bpc.2016.01.003. [DOI] [PubMed] [Google Scholar]
  • 59.de Aquino BRH, Chwastyk M, Mioduszewski Ł, Cieplak M. Networks of interbasin traffic in intrinsically disordered proteins. Phys. Rev. Res. 2020;2:013242. doi: 10.1103/PhysRevResearch.2.013242. [DOI] [Google Scholar]
  • 60.Mioduszewski Ł, Bednarz J, Chwastyk M, Cieplak M. Contact-based molecular dynamics of structured and disordered proteins in a coarse-grained model: Fixed contacts, switchable contacts and those described by pseudo-improper-dihedral angles. Comput. Phys. Commun. 2023;284:108611. doi: 10.1016/j.cpc.2022.108611. [DOI] [Google Scholar]
  • 61.Chwastyk M, Jaskolski M, Cieplak M. Structure-based analysis of thermodynamic and mechanical properties of cavity-containing proteins–Case study of plant pathogenesis-related proteins of class 10. FEBS J. 2014;281:416–429. doi: 10.1111/febs.12611. [DOI] [PubMed] [Google Scholar]
  • 62.Chwastyk M, Jaskolski M, Cieplak M. The volume of cavities in proteins and virus capsids. Proteins. 2016;84:1275–1286. doi: 10.1002/prot.25076. [DOI] [PubMed] [Google Scholar]
  • 63.Chwastyk M, Panek EA, Malinowski J, Jaskolski M, Cieplak M. Properties of cavities in biological structures-A survey of the protein data bank. Front. Mol. Biosci. 2020;7:591381. doi: 10.3389/fmolb.2020.591381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Pall S, et al. Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. J. Chem. Phys. 2020;153:134110. doi: 10.1063/5.0018516. [DOI] [PubMed] [Google Scholar]
  • 65.The PyMOL molecular graphics system. Retrieved from http://www.pymol.org/pymol (2020).
  • 66.DeLano WL. Pymol: An open-source molecular graphics tool. CCP4 Newslett. Protein Crystallogr. 2002;40:82–92. [Google Scholar]
  • 67.Gaussian 16 Rev. C.01 (Wallingford, CT, 2016).
  • 68.Fox T, Kollman PA. Application of the RESP methodology in the parametrization of organic solvents. J. Phys. Chem. B. 1998;102:8070–8079. doi: 10.1021/jp9717655. [DOI] [Google Scholar]
  • 69.Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157–1174. doi: 10.1002/jcc.20035. [DOI] [PubMed] [Google Scholar]
  • 70.Sousa da Silva AW, Vranken WF. ACPYPE—AnteChamber PYthon Parser interfacE. BMC Res. Notes. 2012;5:367. doi: 10.1186/1756-0500-5-367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Darden T, York D, Pedersen L. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089–10092. doi: 10.1063/1.464397. [DOI] [Google Scholar]
  • 72.Andersen HC. Rattle: A “velocity” version of the shake algorithm for molecular dynamics calculations. J. Comput. Phys. 1983;52:24–34. doi: 10.1016/0021-9991(83)90014-1. [DOI] [Google Scholar]
  • 73.Stourac J, et al. Caver Web 1.0: Identification of tunnels and channels in proteins and analysis of ligand transport. Nucleic Acids Res. 2019;47:W414–W422. doi: 10.1093/nar/gkz378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Ho K, Truong DT, Li MS. How good is Jarzynski's equality for computer-aided drug design? J. Phys. Chem. B. 2020;124:5338–5349. doi: 10.1021/acs.jpcb.0c02009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Dudko OK, Hummer G, Szabo A. Intrinsic rates and activation free energies from single-molecule pulling experiments. Phys. Rev. Lett. 2006;96:108101. doi: 10.1103/PhysRevLett.96.108101. [DOI] [PubMed] [Google Scholar]
  • 76.Pham HA, Truong DT, Li MS. Dependence of work on the pulling speed in mechanical ligand unbinding. J. Phys. Chem. B. 2021;125:8325–8330. doi: 10.1021/acs.jpcb.1c01818. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

Data including calculated results of SMD simulations are available in a pdf file while the input files are given in a zip file of the Electronic Supplementary Information (ESI).


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES